To Evaluate the Pharmacokinetics and Safety of TQD3524 for Injection in Renal Impairment Subjects

NCT06522945 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

48

Enrollment

INDUSTRY

Sponsor class

Conditions

Multi-resistant Gram-negative Bacteria Cause Infection

Interventions

DRUG: TQD3524
DRUG: TQD3524
DRUG: TQD3524
DRUG: TQD3524
DRUG: TQD3524
DRUG: TQD3524

Sponsor

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.